Carbapenem-susceptible Acinetobacter baumannii carrying the ISAba1 upstream bla OXA-51-like gene in Porto Alegre, southern Brazil

Epidemiology and Infection

Volumn 141, Issue 2, 2013, Pages 330-333

  Pagano, M ^a   Martins, A F ^b   MacHado, A B M P ^a   Barin, J ^a   Barth, A L ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b Centro Universitario Metodista do IPA   (Brazil)

Author keywords

Antibiotic resistance; emerging infections; hospital acquired (nosocomial) infections; infectious disease epidemiology; molecular epidemiology

Indexed keywords

CARBAPENEM; INTEGRASE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIUM ISOLATION; BLA OXA 23 LIKE GENE; BLA OXA 51 LIKE GENE; BRAZIL; CONTROLLED STUDY; GENE IDENTIFICATION; GENE INSERTION SEQUENCE; HETEROZYGOTE; INTEGRASE GENE; INTEGRON; NONHUMAN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BRAZIL; CARBAPENEMS; CROSS INFECTION; DISEASE OUTBREAKS; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, MICROBIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; INTEGRASES; INTEGRONS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY;

EID: 84876943980     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026881200074X     Document Type: Article

References (14)

1. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clinical Microbiology Reviews 2008; 21: 538-582.
2. Mazel D. Integrons: agents of bacterial evolution. Nature Reviews Microbiology 2006, 4: 608-620. (Pubitemid 44317023)
3. Turton JF, et al. Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom. Journal of Clinical Microbiology 2005; 43: 3074-3082. (Pubitemid 40981305)
4. Turton JF, et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiology Letters 2006; 258: 72-77.
5. Martins AF, et al. High endemic levels of multidrugresistant Acinetobacter baumannii among hospitals in southern Brazil. American Journal of Infection Control 2012; 40: 108-112.
6. Turton JF, et al. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. Journal of Clinical Microbiology 2006; 44: 2974-2976. (Pubitemid 44228598)
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Seventeenth information supplement M100-S17. CLSI, Wayne, PA, USA, 2011.
8. Woodford N, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. International Journal of Antimicrobial Agents 2006; 27: 351-353.
9. Koeleman JGM, et al. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. Journal of Clinical Microbiology 2001; 39: 8-13. (Pubitemid 32059560)
10. Segal H, Garny S, Elisha BG. Is ISABA-1 customized for AcinetobacterFEMS Microbiology Letters 2005; 243: 425-429.
11. Bratu S, et al. Correlation of antimicrobial resistance with b-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City. Antimicrobial Agents and Chemotherapy 2008; 52: 2999-3005.
12. Valenzuela JK, et al. Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii. Journal of Clinical Microbiology 2007; 45: 453-460.
13. Ramirez MS, et al. Increasing frequency of class 1 and 2 integrons in multidrug-resistant clones of Acinetobacter baumannii reveals the need for continuous molecular surveillance. International Journal of Antimicrobial Agents 2011; 37: 175-177.
14. Fonseca EL, et al. Class 2 integrons in multidrugresistant Acinetobacter baumannii circulating in different Brazilian geographic regions. International Journal of Antimicrobial Agents 2011; 38: 95-96.